AI Article Synopsis
- - Imaging plays a crucial role in the evaluation and follow-up of breast cancer, but it should be performed only if it will influence treatment decisions and patient outcomes, such as improving survival or quality of life.
- - There is concern about the overuse of imaging in oncology over the past decade, leading to increased healthcare costs without necessarily benefiting patients.
- - This text reviews the effective use of imaging for different breast cancer stages, including staging for early and advanced cases, surveillance for recurrence, and following up on metastatic breast cancer.
Article Abstract
Imaging in the evaluation and follow-up of patients with early or advanced breast cancer is an important aspect of cancer care. The role of imaging in breast cancer depends on the goal and should only be performed to guide clinical decisions. Imaging is valuable if a finding will change the course of treatment and improve outcomes, whether this is disease-free survival, overall survival or quality-of-life. In the last decade, imaging is often overused in oncology and contributes to rising healthcare costs. In this context, we review the data that supports the appropriate use of imaging for breast cancer patients. We will discuss: 1) the optimal use of staging imaging in both early (Stage 0-II) and locally advanced (Stage III) breast cancer, 2) the role of surveillance imaging to detect recurrent disease in Stage 0-III breast cancer and 3) how patients with metastatic breast cancer should be followed with advanced imaging.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.breast.2016.06.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!